BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.

PHASE4RecruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

December 14, 2020

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2028

Conditions
Takotsubo Syndrome
Interventions
DRUG

Adenosine

Adenosine infusion 70 µg/kg/min for 3 hours.

DRUG

Dipyridamole 200 mg

200 mg b.i.d

DRUG

Apixaban 5 mg Oral Tablet

5mg b.i.d

OTHER

Care as recommended by the Taskforce on Takotsubo Syndrome of the Heart Failure Association of the European Society of Cardiology for takotsubo syndrome

This treatment will vary depending on local routines and the degree of adherence to the recommendations.

Trial Locations (16)

46173

RECRUITING

Norra Älvsborgs länssjukhus, Trollhättan

55111

RECRUITING

Region Jönköpings Län, Jönköping

Unknown

RECRUITING

Aarhus Universitetshospital, Aarhus

RECRUITING

Rigshospitalet, Copenhagen

RECRUITING

Oslo University Hospital, Oslo

RECRUITING

Region Dalarna, Falun

RECRUITING

Sahlgrenska University Hospital, Department of Cardiology, Gothenburg

RECRUITING

Skaraborg Hospital, Gothenburg

RECRUITING

Region Skane Helsingborg Hospital, Helsingborg

RECRUITING

Region Oestergoetland, Linköping

RECRUITING

Region Skane - Skanes Universitetssjukhus, Lund

RECRUITING

Region Orebro lan, Örebro

RECRUITING

Danderyds Hospital, Department of Cardiology, Stockholm

RECRUITING

Karolinska University Hospital, Huddinge, Department of Cardiology, Stockholm

RECRUITING

Umeå University Hospital, Department of Cardiology, Umeå

831 27

RECRUITING

Östersund Sjukhus, Östersund

All Listed Sponsors
collaborator

Göteborg University

OTHER

lead

Vastra Gotaland Region

OTHER_GOV